FDAnews
www.fdanews.com/articles/158386-antiviral-drug-may-extend-brain-cancer-survival-researchers-say

Antiviral Drug May Extend Brain Cancer Survival, Researchers Say

September 5, 2013
An early study published in the New England Journal of Medicine claims that the antiviral drug Valcyte may lengthen the lives of patients with glioblastoma, one of the most deadly forms of brain cancer.
HealthDay